Abstract
Background
Obstructive sleep apnea–hypopnea syndrome (OSAHS) is considered a comorbidity associated with morbid obesity, mainly because of the large neck circumference. Depending on its severity, OSAHS can interfere in many homeostasis systems, for example, the central nervous system (CNS). Neuron-specific enolase (NSE) and S100B protein derived from astrocytes are considered sensitive biochemical markers of cerebral injury. We evaluated serum S100B and NSE levels in this study with the aim of detecting possible cerebral injury as a consequence of OSAHS.
Methods
This was a transverse study with data from 25 morbidly obese patients with OSAHS. Blood samples were collected before and after polysomnography (PSG) to determine S100B and NSE protein levels. We also analyzed data evaluating depression and excessive daytime sleepiness.
Results
S100B levels were higher after [0.029 (0.010–0.199) mg/l] compared to before [0.010 (0.010–0.025) mg/l] on PSG (P = 0.002). S100B levels were expressed as means and IQ25–IQ75. NSE levels did not show significant differences before and after PSG.
Conclusion
Our study shows a significant increase in S100B level after PSG compared to before. This suggests that there is a CNS astrocyte reaction because of possible cerebral hypoxemia in morbidly obese patients with OSAHS.
Similar content being viewed by others
Abbreviations
- OSAHS:
-
obstructive sleep apnea–hypopnea syndrome
- CNS:
-
central nervous system
- S100B:
-
a protein derived from astrocyte activity
- NSE:
-
neuron-specific enolase (a glycolytic pathway enzyme from CNS)
- PSG:
-
polysomnography
- AHI:
-
apnea–hypopnea index
- EDS:
-
excessive daytime sleepiness
References
Fritscher LG, Mottin CC, Canani S, Chatkin JM. Obesity and obstructive sleep apnea–hypopnea syndrome: the impact of bariatric surgery. Obes Surg. 2007;17:95–9.
Peiser J, Lavie, P, Ovnat A, Charuzi I. Sleep apnea syndrome in the morbidly obese as an indication for weight reduction surgery. Ann Surg. 1984;100:112–15.
Caples SM, Gami AS, Somers VK. Obstructive sleep apnea. Ann Intern Med. 2005;142:187–97.
Naegele B, Thouvard V, Pepin JL, Levy P, Bonnet C, et al. Deficits of cognitive executive functions in patients with sleep apnea syndrome. Sleep. 1995;18:43–52.
Macey PM, Henderson LA, Macey KE, Alger JR, Frysinger RC, et al. Brain morphology associated with obstructive sleep apnea. Am J Respir Crit Care Med. 2002;166:1382–7.
Morrell MJ, McRobbie DW, Quest RA, Cummin AR, Ghiassi R, et al. Changes in brain morphology associated with obstructive sleep apnea. Sleep Med. 2003;4:451–4.
Braga CW, et al. S100B and NSE serum levels in obstructive sleep apnea syndrome. Sleep Med. 2006;12:1–5.
Jordan W, Hagedohm J, Wiltfang J, et al. Biochemical markers of cerebrovascular injury in sleep apnoea syndrome. Eur Respir J. 2002;20:158–64.
Van Eldik LJ, Wainwright MS. The Janus face of glial-derived S100B: beneficial and detrimental functions in the brain. Restor Neurol Neurosci. 2003;21:97–108.
Donato R. Intracellular and extracellular roles of S100 proteins. Microsc Res Tech. 2003;60:540–51.
Kayser E, Kaiser R, Kuzmits P, et al. Clinical biochemistry of neuron specific enolase. Clin Chim Acta. 1989;183:13–32.
Busnello JV. Acute and chronic electroconvulsive shock in rats: effects on peripheral markers of neuronal injury and glial activity. Life Sci. 2006;78:3013–17.
Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–71.
Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14:540–5.
Rechtschaffen A, Kales AA. A manual of standardized terminology, techniques, and scoring system for sleep stages of human subjects. Washington, DC: Public Health Service; 1968.
Guardiano SA, Scott JA, Ware C, Schechner SA. The long-term results of gastric bypass on indexes of sleep apnea. Chest. 2003;124:1615–19.
Rasheid S, Banasiak M, Gallagher SF, et al. Gastric bypass is an effective treatment for obstructive sleep apnea in patients with clinically significant obesity. Obesity Surgery. 2004;13:58–61.
Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–37.
Mazzini G, Schaf D, Oliveira AR, Goncalves CA, Souza DO, Portela LV. The ischemic rat heart releases S100B. Life Sci. 2005;77:882–89.
Willoughby KA, Kleindienst A, Müller C, Chen T, Muir JK, Ellis EF. S100B protein is released by in vitro trauma and reduces delayed neuronal injury. J Neurochem. 2004;91:1284–91.
Rothermundt M, Peters M, Prehn J, Arolt V. S100B in brain damage and neurodegeneration. Microsc Res Techn. 2004;60:614–32.
Herrmann M, Vos P, Wunderlich MT, de Bruijn CH, Lamers KJ. Release of glial tissue-specific proteins after acute stroke: a comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein. Stroke. 2000;31:2670–7.
Gale SD, Hopkins RO. Effects of hypoxia on the brain: neuroimaging and neuropsychological findings following carbon monoxide poisoning and obstructive sleep apnea. J Int Neurops Soc. 2004;10:60–71.
Halbower AC, Degaonkar M, Barker PB, Earley CJ, Marcus CL, Smith PL, et al. Childhood obstructive sleep apnea associates with neuropsychological deficits and neuronal brain injury. Plos Med. 2006;3:301.
Morrell MJ, McRobbie DW, Quest RA, Cummin AR, Ghiassi R, et al. Changes in brain morphology associated with obstructive sleep apnea. Sleep Med. 2003;4:451–4.
Pleines UE, Morganti-Kossmann MC, Rancan M, Joller H, Trentz O, Kossmann T. S-100 beta reflects the extent of injury and outcome, whereas neuronal specific enolase is a better indicator of neuroinflammation in patients with severe traumatic brain injury. J Neurotrauma. 2001;18:491–8.
Hu J, Ferreira A, Van Eldik LJ. S100beta induces neuronal cell death through nitric oxide release from astrocytes. J Neurochem. 1997;69:2294–301.
Tramontina F, Conte S, Gonçalves D, Gottfried C, Portela LV, Vinade L, et al. Developmental changes in S100B content in brain tissue, cerebrospinal fluid, and astrocyte cultures of rats. Cell Mol Neurobiol. 2002;22:373–8.
Tramontina F, Tramontina AC, Souza DF, Leite MC, Gottfried C, Souza DO, et al. Glutamate uptake is stimulated by extracellular S100B in hippocampal astrocytes. Cell Mol Neurobiol. 2006;26:81–6.
Arolt V, Peters M, Erfurth A, Wiesmann M, Missler U, Rudolf S, et al. S100B and response to treatment in major depression: a pilot study. Eur Neuropsychopharmacol. 2003;13:235–9.
Hetzel G, Moeller O, Evers S, Erfurth A, Ponath G, Arolt V, et al. The astroglial protein S100B and visually evoked event-related potentials before and after antidepressant treatment. Psychopharmacology. 2005;178:161–6.
Sriram K, Benkovic SA, Miller DB, O’Callaghan JP. Obesity exacerbates chemically induced neurodegeneration. Neuroscience. 2002;115:1335–46.
Acknowledgments
Special thanks for Dr Claudio Corá Mottin; Dr Diogo Onofre Souza; Dr Luiz Valmor Portela and Dr Renato Dutra Dias; for always stimulating the integration between Clinical and Basic Sciences Research.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
da Silva, L.G., Mottin, C.C., Souza, D.O. et al. Serum S100B but not NSE Levels are Increased in Morbidly Obese Individuals Affected by Obstructive Sleep Apnea–Hypopnea Syndrome. OBES SURG 18, 993–999 (2008). https://doi.org/10.1007/s11695-007-9386-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-007-9386-6